BioSpace News Archive

Company launches Time to Evolve campaign to equip surgeons and hospital systems with tools and resources to support their evolution to less invasive surgical techniques

BTIG announced today that the “BTIG Virtual Biotechnology Conference” will take place on Monday, August 10 th through Tuesday, August 11, 2020. The conference will be hosted by BTIG Biotechnology Analysts Dae Gon Ha, PhD, Julian Harrison, Robert “Bert” Hazlett , and Thomas Shrader, PhD, CFA , as well as BTIG Healthcare Stra

Jaguar Health, Inc. (NASDAQ:JAGX) announced today that the 28-day preclinical toxicology and safety study in rats began yesterday to support development of lechlemer, the second generation, plant-based anti-secretory drug candidate of Napo Pharmaceuticals

DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and human services provider to the federal government, will release its financial results for the fiscal third quarter ended June 30, 2020 on August 5, 2020 after the market close

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa , Ph.D., “Astellas”) today announced it has been awarded a grant from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH) in the U.S. to help fund two phase 1 clinical studies to evaluate the safety and efficacy of ASP8062, an oral small

The hospital is the only hospital with the Employers Centers of Excellence Network that has the designation for cardiac, spine, bariatrics and hip and knee replacement surgeries in the country

Swift Biosciences, Inc., a leader in the commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), has signed an agreement to supply its Swift 2S® Turbo DNA Library Kits to Otogenetics Corporation, a high throughput NGS clinical lab offering Prenatal Testing, Deafness Testing, Hereditary Cancer

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced the pricing of an underwritten public offering of 20,000,000 shares of its common stock at a price to the public of $1.90 per share.

New grant expands coverage of key U.S. platform patent to Europe ENDRA Life Sciences Inc.

BOSTON, MA / ACCESSWIRE / July 22, 2020 / AG Mednet , a technology company streamlining, automating and increasing data quality for clinical trials, announces significant expansion to its Submission Quality and Compliance (SQC) Toolkit.